Micropaque suspension ® / Micropaque scanner ® / Microtrast ® The Micropaque ® range was launched in France in 1983. France Products & Solutions Contrast products Micropaque suspension® / Micropaque scanner® / Microtrast® Diagnostic imaging solution Motivated by its commitment to advancing radiology today and in the future, Guerbet's diagnostic medical imaging department has designed a comprehensive range of interconnected solutions. Interconnected solutions for diagnostic imaging Contrast media for X-ray imaging Summary of Product Characteristics, Package Leaflet and Transparency Notice Micropaque suspension ® Summary of Product Characteristics, Package Leaflet and Transparency Notice Micropaque scanner ® Summary of Product Characteristics and Microtrast ® Package Leaflet Do you want to report an adverse reaction that has occurred with one of our medicines? Contact us Contact Publications Conventions / Benefits Legal information Copyright © Guerbet 2020 LinkedIn Twitter Instagram Youtube Use of cookies This website uses cookies to provide you with optimized navigation and to analyze visitor traffic. By continuing to browse this site without changing your settings, you accept the use of cookies. Find out more OK Welcome to Guerbet France

Webinar: Update on Iodinated Contrast Media Administration: The Impact of New CT Technology December 15th at 1pm CET or 8pm CET Read More Guerbet reveals its Purpose, a strategic guide for its actions and decisions Read more Guerbet reveals its Purpose, a strategic guide for its actions and decisions 2020 revenue Webinar: Update on Iodinated Contrast Media Administration Guerbet Switzerland GUERBET has been an active presence on the Swiss radiological scene for many decades now. It all started in the early 60s, and more precisely in 1963 when the company Max Ritter Pharma began distributing GUERBET contrast media. This changed in the 80s, when the GUERBET group established a direct presence in some European countries. On July 1, 1987 the Swiss subsidiary, GUERBET AG was founded with its sales reps’ team composed of former Max Ritter Pharma employees. The first gadolinium-based contrast agent was launched shortly afterwards. Read more Contact us Read more Pharmacovigilance Read more Let’s get connected Media Legal Information Pharmacovigilance Contact us Copyright © Guerbet 2021 LinkedIn Twitter Instagram YouTube Cookies Guerbet uses cookies to improve your experience and to analyze traffic patterns of visitors. By continuing your visit on this website without changing your settings, you consent to the use of cookies in accordance with our Cookie Policy. Find out more OK Welcome to Guerbet Switzerland